6 December 2024 in Materials Today Bio
Bacterial infections significantly threaten human health, leading to severe diseases and complications across multiple systems and organs. Antibiotics remain the primary treatment strategy for these infections. However, the growing resistance of bacteria to conventional antibiotics underscores the urgent need for safe and effective alternative treatments. In response, several approaches have been developed, including carbon dots (CDs), antimicrobial peptides, and antimicrobial polymers, all of which have proven effective in combating bacterial resistance. Among these, CDs stand out due to their unique advantages, including low preparation cost, stable physicochemical properties, high biocompatibility, tunable surface chemistry, strong photoluminescence, and efficient generation of reactive oxygen species. These features make CDs highly promising in antibacterial applications. This review explores the development of antibacterial CDs, focusing on their mechanisms of action—physical destroy, biochemical damage, and synergistic effects—while highlighting their potential for clinical use as antibacterial agents.
1 June 2025 in Bioactive Materials
Periodontitis is a chronic inflammatory disease primarily caused by bacteria, leading to inflamed and bleeding gums, periodontal pocket formation, and bone loss. Affecting 70%-90% of adults over 65, periodontitis is a leading cause of tooth loss and significantly impacts quality of life. Standard treatments, including subgingival scraping and antibiotics, have limitations, and antibiotic resistance among periodontal pathogens is an increasing concern. Biofilms are barriers to drugs and immune responses, contributing to bacterial resistance and reducing antibiotic effectiveness. Due to their adjustable physicochemical properties, bioactive materials potentially eliminate bacterial biofilms, presenting a promising alternative for periodontitis therapy. In this review, the recent innovations in biomaterials for removing mature biofilms in periodontitis are examined, and their broader potential is discussed. Additionally, the compositions of bacterial biofilms, formation pathways, and intrinsic drug resistance mechanisms are discussed. Finally, the strategies for optimizing subgingival biofilm removal in periodontitis are highlighted, such as targeting biofilms-embedded bacteria, disrupting the extracellular polymeric substances, and utilizing combined approaches. A comprehensive understanding of the properties of biomaterials guides the rational design of highly targeted and effective therapies for periodontitis.
23 May 2025 in Biomaterials
17 September 2025 in Advanced Science
Intervertebral disc degeneration (IVDD) is a progressive degenerative disorder of the spine characterized by oxidative stress and cellular dysfunction. Current clinical treatments for IVDD include surgical procedures, such as discectomy and spinal fusion, as well as pharmacological therapies using analgesics and anti‐inflammatory agents. However, these strategies primarily offer symptomatic relief and do not address the underlying causes of IVDD. Targeting oxidative stress has emerged as a promising therapeutic approach, yet its effectiveness remains limited. To overcome this limitation, an antioxidant carbon dot of selenomethionine (Se‐Met‐CD) is developed for efficient IVDD therapy. Se‐Met‐CD effectively scavenges excess reactive oxygen species (ROS), alleviates oxidative stress, and restores intracellular redox homeostasis in nucleus pulposus cells. Se‐Met‐CD exhibits an antioxidant capacity 3.1 times that of its precursor, Se‐Met, when compared at the same concentration. In hydrogen peroxide (H 2 O 2 )‐treated nucleus pulposus cells, Se‐Met‐CD significantly reduces intracellular ROS levels to 17.7% of those in untreated control cells. In a puncture‐induced IVDD rat model, Se‐Met‐CD demonstrates remarkable therapeutic efficacy by significantly attenuating disc degeneration, reflected in lower Pfirrmann and histological scores. These results underscore the potential of Se‐Met‐CD to treat IVDD by scavenging ROS, restoring antioxidant balance, and modulating the local microenvironments.
24 September 2025 in Journal of Advanced Research
Dentin hypersensitivity (DH) is a prevalent and acute dental pain disorder marked by a brief yet sharp toothache caused by exposed dentin, often in response to thermal, chemical, and mechanical stimuli. It significantly affects a person's quality of life, interfering with routine activities, such as eating and drinking. With an improved understanding of the mechanisms underlying DH, various physical and chemical strategies have been developed to alleviate the condition. This review evaluates three principal mechanistic theories underlying DH desensitization, including the Direct Innervation Hypothesis, the Odontoblast Receptor Theory, and the Hydrodynamic Theory. It provides a detailed analysis of current physical, chemical, and synergistic therapeutic methods used for desensitization. Additionally, it discusses potential future therapeutic approaches for the treatments of DH. This review highlights recent advancements and ongoing challenges in applying physical and chemical strategies for DH therapy. It also discusses potential future strategies and methods, offering insights into the prospects for the field.
12 December 2025 in Biomaterials